periodontal disease. Gingivitis and periodontal diseases
Conditions
Interventions
Intervention 1: Intervention group: In a 14-day period of chemotherapy, patients after receiving routine periodontal treatment (SRP), one day between and at the end of a period of chemotherapy with th
Sponsors
Artesh University of Medical Sciences
Eligibility
Sex/Gender
All
Age
No minimum to 65 Years
Inclusion criteria
Inclusion criteria: presence of periodontal disease at least in one tooth Age < 65 years
Exclusion criteria
Exclusion criteria: Pregnancy or lactating Medication (i.e., antibiotics) affecting periodontal status Not receiving routine periodontal treatment (SRP) in the last 6 months
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain/Burning. Timepoint: Baseline, 7, 14 days after starting chemotherapy period. Method of measurement: Visual Analogue Scale.;Probing Depth. Timepoint: Baseline, 7, 14 days after starting chemotherapy period. Method of measurement: The distance measured from the base of the pocket to the most apical point on the gingival margin.;Plaque Index. Timepoint: Baseline, 7, 14 days after starting chemotherapy period. Method of measurement: The plaque index quantitatively assesses the amount of dental plaque visible on the surfaces of all teeth, except the third molars.;Gingival Index. Timepoint: Baseline, 7, 14 days after starting chemotherapy period. Method of measurement: The Gingival Index (GI) scores each site on a 0 to 3 scale, with 0 being normal and 3 being severe inflammation characterized by edema, redness, swelling, and spontaneous bleeding.;Bleeding on probing (BoP). Timepoint: Baseline, 7, 14 days after starting chemotherapy period. Method of measurement: Visual evaluation of bleeding. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactParsa Firoozi
Artesh University of Medical Sciences
Outcome results
None listed